Outcome assessment of disease modification represents a major challenge to the development of therapies and management of spondyloarthritis, particularly for patients with axial disease. Could a new approach to imaging assessment of the spine using low-dose CT provide an answer to this perennial problem?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MRI-based synthetic CT for assessment of the bony elements of the sacroiliac joints in children
Insights into Imaging Open Access 18 February 2024
-
The value of MRI compared to conventional radiography in analysing morphologic changes in the spine in axial spondyloarthritis
Insights into Imaging Open Access 11 December 2021
-
MRI compared with low-dose CT scanning in the diagnosis of axial spondyloarthritis
Clinical Rheumatology Open Access 03 December 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
De Bruin, F. et al. Development of the CT Syndesmophyte Score (CTSS) in patients with ankylosing spondylitis: data from the SIAS cohort. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2017-212553 (2017).
De Koning, A. et al. Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2017-211989 (2017).
Creemers, M. C. et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann. Rheum. Dis. 64, 127–129 (2005).
Spoorenberg, A. et al. Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. J. Rheumatol. 31, 125–132 (2004).
Baraliakos, X. et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann. Rheum. Dis. 66, 910–915 (2007).
Tan, S. et al. Quantitative measurement of syndes-mophyte volume and height in ankylosing spondylitis using CT. Ann. Rheum. Dis. 73, 544–550 (2014).
Mettler, F. A. Jr et al. Effective doses in radiology and diagnostic nuclear medicine. Radiology 248, 254–263 (2008).
Van Tubergen, A. et al. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study. Ann. Rheum. Dis. 71, 518–523 (2012).
Machado, P. M. et al. MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis. Ann. Rheum. Dis. 75, 1486–1493 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Maksymowych, W., Lambert, R. Low-dose CT for spondyloarthritis — a brilliant new chapter?. Nat Rev Rheumatol 14, 130–131 (2018). https://doi.org/10.1038/nrrheum.2018.4
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2018.4
This article is cited by
-
MRI-based synthetic CT for assessment of the bony elements of the sacroiliac joints in children
Insights into Imaging (2024)
-
The value of MRI compared to conventional radiography in analysing morphologic changes in the spine in axial spondyloarthritis
Insights into Imaging (2021)
-
Acute Sacroiliac Joint Pain: Clinical Presentation, Causes, and Investigations
Current Treatment Options in Rheumatology (2021)
-
MRI compared with low-dose CT scanning in the diagnosis of axial spondyloarthritis
Clinical Rheumatology (2020)
-
Radiologic approach to axial spondyloarthritis: where are we now and where are we heading?
Rheumatology International (2018)